5U2V image
Deposition Date 2016-12-01
Release Date 2017-02-08
Last Version Date 2024-11-06
Entry Detail
PDB ID:
5U2V
Keywords:
Title:
Structure of human MR1-HMB in complex with human MAIT A-F7 TCR
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.22
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Major histocompatibility complex class I-related gene protein
Gene (Uniprot):MR1
Chain IDs:A, E (auth: C)
Chain Length:271
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Beta-2-microglobulin
Gene (Uniprot):B2M
Chain IDs:B, F (auth: D)
Chain Length:99
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:MAIT T-cell receptor alpha chain
Chain IDs:C (auth: G), G (auth: E)
Chain Length:203
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:MAIT T-cell receptor beta chain
Chain IDs:D (auth: H), H (auth: F)
Chain Length:245
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
Nat. Immunol. 18 402 411 (2017)
PMID: 28166217 DOI: 10.1038/ni.3679

Abstact

The major-histocompatibility-complex-(MHC)-class-I-related molecule MR1 can present activating and non-activating vitamin-B-based ligands to mucosal-associated invariant T cells (MAIT cells). Whether MR1 binds other ligands is unknown. Here we identified a range of small organic molecules, drugs, drug metabolites and drug-like molecules, including salicylates and diclofenac, as MR1-binding ligands. Some of these ligands inhibited MAIT cells ex vivo and in vivo, while others, including diclofenac metabolites, were agonists. Crystal structures of a T cell antigen receptor (TCR) from a MAIT cell in complex with MR1 bound to the non-stimulatory and stimulatory compounds showed distinct ligand orientations and contacts within MR1, which highlighted the versatility of the MR1 binding pocket. The findings demonstrated that MR1 was able to capture chemically diverse structures, spanning mono- and bicyclic compounds, that either inhibited or activated MAIT cells. This indicated that drugs and drug-like molecules can modulate MAIT cell function in mammals.

Legend

Protein

Chemical

Disease

Primary Citation of related structures